Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785324 · ClinicalTrials.gov registry record · NA
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
A NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL), sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06785324 is a NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL) that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 20 participants, below the 85-participant average among 7 other B-ALL trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06785324, a NA study of B-ALL and B-cell Acute Lymphoblastic Leukemia (B-ALL), is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy. Participants will take part in 2 different interventions: * Nutrition Intervention * Physical Exercise Intervention All subjects will be provided with a wearable electronic activity monitor (FitBit®) to assist in recording activity levels in minutes of activity.
Conditions Studied
Interventions
- BEHAVIORAL Nutrition Intervention
- BEHAVIORAL Exercise intervention
Study Locations (1)
Illinois
- University of Chicago Medicine Comprehensive Cancer Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2027-11-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06785324
The ClinicalTrials.gov registry entry for NCT06785324 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 7 other B-ALL trials with a reported enrollment target (76% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with B-ALL appearing as the primary indexed condition, and to 2 interventions - of which Nutrition Intervention is the first listed.
NCT06785324 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06785324 about?
NCT06785324 is a clinical study titled "Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)". This clinical trial aims to assess the effect of nutrition and exercise on muscle and adiposity in adults with Philadelphia Chromosome (Ph) Negative B-ALL undergoing inpatient induction therapy. Participants will take part in 2 different interventions: * Nutrition Intervention * Physical Exercise ...
What is the current status of trial NCT06785324?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-05-12. Estimated completion is 2027-11-06.
What conditions does trial NCT06785324 study?
This clinical trial studies the following conditions: B-ALL, B-cell Acute Lymphoblastic Leukemia (B-ALL), Philadelphia Chromosome Negative.
What interventions are being tested in trial NCT06785324?
The interventions under investigation include: Nutrition Intervention (BEHAVIORAL), Exercise intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06785324?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06785324 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for B-ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
RECRUITING · NA
-
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
RECRUITING · Phase 1
-
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
RECRUITING · Early Phase 1
-
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
RECRUITING
-
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
RECRUITING · Phase 1
-
Autologous CD22 CAR T Cells in Adults w/ Recurrent or Refractory B Cell Malignancies
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.